An analysis of the reporting of results in lung cancer drug trials.
D000970:Antineoplastic Agents / Q000009:adverse effects; D002986:Clinical Trials as Topic / Q000592:standards*; D004334:Drug Administration Schedule; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D008523:MEDLARS; D009362:Neoplasm Metastasis; D010506:Periodicals as Topic; D013997:Time Factors; D014481:United States
D000970:Antineoplastic Agents